ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,321.41
      0.25%
      US Tech 100
      18,232.00
      0.00%
      Dow Jones
      39,872.99
      0.17%
      Brent Oil
      81.695
      -0.91%
      Bitcoin
      69,622.09
      -0.73%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Global Blood Therapeutics Inc (GBT)

      7. Global Blood Therapeutics Inc (GBT) News

      GBT

      Global Blood Therapeutics (GBT)

      Global Blood Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:GBT
      DateTimeSourceHeadlineSymbolCompany
      02/09/202311:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/17/20228:34AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/06/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:41PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:37PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:33PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:28PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:22PMEdgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/05/20229:00AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:GBTGlobal Blood Therapeutics Inc
      10/04/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GBTGlobal Blood Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:GBT

      Your Recent History

      AMEX
      CMQ
      Cathay Merchant
      TSXV
      SUGR.H
      SugarBud Craft Growers
      Delayed Upgrade Clock